Principal Financial Group Inc. (PFG)
Principal Financial Group: Share Buybacks Drive Share Value Growth
Principal Financial Group offers a compelling dividend growth opportunity, operating behind the scenes in financial services with $1.8 trillion in assets under administration. PFG targets 9%-12% annual non-GAAP EPS growth, supported by strong Q3 2025 results, disciplined capital allocation, and a 16-year dividend growth streak. Shares trade at a forward P/E of 9.3, below the 10-year average, offering a 3.7% yield and potential for a 28% total return by 2026 if growth forecasts are met.
Principal Financial (PFG) Up 3% Since Last Earnings Report: Can It Continue?
Principal Financial (PFG) reported earnings 30 days ago. What's next for the stock?
Principal Financial Group, Inc. (PFG) Q3 2025 Earnings Call Transcript
Principal Financial Group, Inc. (NASDAQ:PFG ) Q3 2025 Earnings Call October 28, 2025 10:00 AM EDT Company Participants Humphrey Lee - VP & Head of Investor Relations Deanna Strable - President, CEO & Chair of the Board Joel Pitz - Executive VP & CFO Christopher Littlefield - President of Retirement & Income Solutions Amy Friedrich - President of Benefits & Protection Kamal Bhatia - President & CEO of Principal Asset Management Conference Call Participants Francis Matten - BMO Capital Markets Equity Research Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division John Barnidge - Piper Sandler & Co., Research Division Jamminder Bhullar - JPMorgan Chase & Co, Research Division Wilma Jackson Burdis - Raymond James & Associates, Inc., Research Division Joel Hurwitz - Dowling & Partners Securities, LLC Suneet Kamath - Jefferies LLC, Research Division Thomas Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Carmichael - Autonomous Research US LP Presentation Operator Good morning, and welcome to the Principal Financial Group Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference over to Humphrey Lee, Vice President of Investor Relations.
Principal Financial Q3 Earnings & Revenues Lag Estimates, Dividend Up
PFG's Q3 results reflect solid performance across most of the segments, offset by higher expenses.
Here's Why Principal Financial (PFG) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Principal Financial: Cheap Enough To Buy Given Capital Returns (Upgrade)
I'm upgrading Principal Financial Group to a "Buy," as it offers 5%-10% upside plus a 4% dividend yield for value-focused investors. Recent results showed solid margin expansion and capital returns, despite mixed performance in asset management and actuarial reserve adjustments. PFG's capital return strategy, including $1.6 billion expected next year, supports a fair value in the mid-to-upper $80s per share.
Is a Beat in the Cards for Principal Financial This Earnings Season?
PFG's Q3 results are likely to reflect increased average AUM, higher average invested assets, and favorable market performance.
Exploring Analyst Estimates for Principal Financial (PFG) Q3 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Principal Financial (PFG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Why Principal Financial (PFG) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Principal Financial (PFG) have what it takes?
Xenon Pharmaceuticals Inc. - Special Call
Xenon Pharmaceuticals Inc. - Special Call Company Participants Ian Mortimer - Interim CFO, President, CEO, Principal Financial Officer, Principal Accounting Officer & Director James Empfield - Executive Vice President of Drug Discovery JP Gilbert Christopher Kenney - Chief Medical Officer Presentation Ian Mortimer Interim CFO, President, CEO, Principal Financial Officer, Principal Accounting Officer & Director Good morning, everyone. My name is Ian Mortimer, I'm the President and CEO of Xenon Pharmaceuticals, and I will be moderating today's session.
Can Principal Financial Balance Growth With Margin Pressures?
PFG benefits from retirement leadership, fee-based income, and consistent shareholder returns despite margin pressures.
Principal Financial Group, Inc. (PFG) Q2 2025 Earnings Call Transcript
Principal Financial Group, Inc.(NASDAQ:PFG ) Q2 2025 Earnings Conference Call July 29, 2025 10:00 AM ET Company Participants Amy Christine Friedrich - President of Benefits & Protection Christopher James Littlefield - President of Retirement & Income Solutions Deanna Dawnette Strable-Soethout - President, CEO & Director Humphrey Lee - VP & Head of Investor Relations Joel Michael Pitz - Executive VP & CFO Kamal Bhatia - President & CEO of Principal Asset Management Conference Call Participants Jack Matten - BMO Capital Markets Equity Research Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division Joel Robert Hurwitz - Dowling & Partners Securities, LLC John Bakewell Barnidge - Piper Sandler & Co., Research Division Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L. Kamath - Jefferies LLC, Research Division Taylor Alexander Scott - Barclays Bank PLC, Research Division Thomas George Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Collin Carmichael - Autonomous Research US LP Operator Good morning, and welcome to the Principal Financial Group Second Quarter 2025 Financial Results Conference Call.
